From Cabot Top Ten Trader
Overall, we’d say the story remains largely the same—there are some chinks in the armor overall, including some tertiary sentiment stuff (especially in the options markets) and short-term momentum measures (as the Nasdaq tested its highs yesterday, just 100 hit...
Read More
Gun sales have seen a surge of late, and Smith & Wesson stock has gotten a big boost. Here's why the best is yet to come for this small cap.
Read More
The big news affecting the market this week is the upward trend in coronavirus cases in some states and the resulting concern that an economic rebound will be curbed sooner than hoped.
Read More
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
The market continues to recover from last week’s short but intense decline. In our portfolio there’s been a dearth of news flow. That’s fine with me. I think we could all use a little less stimulation and step back from our computers and devices...
Read More
Markets rebounded this past month, albeit with plenty of volatility. But the net result was a 1,500+ gain in the Dow Jones Industrial Markets.
Unemployment, of course, is still pressuring the economy, with some 29.5 million Americans without jobs. However, the housing market perked with...
Read More
We’re finally starting to see signs that investors are realizing that risk actually does exist in the market (I think).
Read More
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
In the market, there seems to be some rotation going on. Or at least that was my sense of things over the first two and a half trading days of the week.
Read More
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
Apple and Amazon are two of the most recognizable names on the planet, and good stocks. Which is the better buy? Let's break down Amazon vs. Apple stock.
Read More
Enjoy the current strength but be aware of the environment we’re in, and why. Accept that we could see a significant retreat in the prices of many of our stocks in the near term, but that the fundamental reasons behind their current strength persist...
Read More
While we are definitely not out of the woods yet—with the economy and the markets—we are making progress. The Dow Jones Industrial Average has had a nice bounce back, albeit, with some volatility. We can expect that to continue, probably through year-end. As can...
Read More
Under normal market conditions growth investors like to get pulled into strong stocks and buy them as they head higher. This is anything but a normal market, however!
Read More
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
The market continues to remain strong in the face of economic data that’s anything but. As we’ve already discussed at great length, this is because the market is forward looking and there’s been enough potential positive news around treatments and the timeline to vaccine...
Read More
Our Emerging Markets Timer as found support in recent weeks, but that hasn’t been enough to produce a new buy signal.
Read More
The S&P 500 crossed above its 25-day moving average line on April 6 and is back above its 50-day moving average line today. It is only 16% off its previous high. Granted, under the circumstances that doesn’t seem quite right. But nevertheless, there is...
Read More
For-profit education is flourishing under the Trump administration. Here are the for-profit education stocks I like best.
Read More
As we move closer to the end of another week, investors continue to focus on the potential timeline to open parts of the economy. New York has just said the lockdown for non-essential businesses remains in effect for at least another month, but there...
Read More
